anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
The primary objectives of the project are to describe perioperative cognitive trajectories of older patients whose elective noncardiac surgery has been deferred because of the COVID-19 emergency, and explore the intra-individual changes in these trajectories from before to after surgery, through periodic remote self-administered cognitive testing. Secondarily, in the same patients, the investigators will also describe the perioperative trajectories in depressive symptoms and pain, and study their correlation with the trajectories in cognitive performance.

The study will be conducted remotely and virtually. The investigators will have an initial videoconference with the participant (and a support person if necessary) to explain the computerized cognitive test battery (i.e. the Cogstate Brief battery, CBB), and train on self-administration through a user-specific link. At each due assessment, the research team will call the participant to remind to complete the CBB; and to assess depressive symptoms, pain, and collect data on intercurrent clinical events (i.e. medication changes, hospitalization, ED or urgent care visits).
This group will receive Ericksonian Hypnotherapy, a therapeutic approach that utilizes techniques of hypnosis and suggestion to access and alter subconscious processes, aiming to reduce psychological distress associated with depression and anxiety. Similar to the CBT group, sessions are delivered in person on a one-on-one basis, with a total of 12 weekly sessions, each one hour long.
Over the past decade, the development of three-dimensional (3D) models has increased exponentially, facilitating the unravelling of fundamental and essential cellular mechanisms by which cells communicate with each other, assemble into tissues and organs and respond to biochemical and biophysical stimuli under both physiological and pathological conditions. This section presents a concise overview of the most recent updates on the significant contribution of different types of 3D cell cultures including spheroids, organoids and organ-on-chip and bio-printed tissues in advancing our understanding of cellular and molecular mechanisms. The case studies presented include the 3D cultures of breast cancer (BC), endometriosis, the liver microenvironment and infections. In BC, the establishment of 3D culture models has permitted the visualization of the role of cancer-associated fibroblasts in the delivery of exosomes, as well as the significance of the physical properties of the extracellular matrix in promoting cell proliferation and invasion. This approach has also become a valuable tool in gaining insight into general and specific mechanisms of drug resistance. Given the considerable heterogeneity of endometriosis, 3D models offer a more accurate representation of the in vivo microenvironment, thereby facilitating the identification and translation of novel targeted therapeutic strategies. The advantages provided by 3D models of the hepatic environment, in conjunction with the high throughput characterizing various platforms, have enabled the elucidation of complex molecular mechanisms underlying various threatening hepatic diseases. A limited number of 3D models for gut and skin infections have been developed. However, a more profound comprehension of the spatial and temporal interactions between microbes, the host and their environment may facilitate the advancement of in vitro, ex vivo and in vivo disease models. Additionally, it may pave the way for the development of novel therapeutic approaches in diverse research fields. The interested reader will also find concluding remarks on the challenges and prospects of using 3D cell cultures for discovering cellular and molecular mechanisms in the research areas covered in this review.
Recent advances in clinical prediction for diarrhoeal aetiology in low- and middle-income countries have revealed that the addition of weather data to clinical data improves predictive performance. However, the optimal source of weather data remains unclear. We aim to compare the use of model estimated satellite- and ground-based observational data with weather station directly observed data for the prediction of aetiology of diarrhoea. We used clinical and etiological data from a large multi-centre study of children with moderate to severe diarrhoea cases to compare their predictive performances. We show that the two sources of weather conditions perform similarly in most locations. We conclude that while model estimated data is a viable, scalable tool for public health interventions and disease prediction, given its ease of access, directly observed weather station data is likely adequate for the prediction of diarrhoeal aetiology in children in low- and middle-income countries.
A quick-acting medicine for treating Japanese encephalitis is a Chinese-Western compound preparation, wherein the medicine includes the following traditional Chinese medicines: artemisia argyi, Chinese onion, borneol, musk and dates, which have the effects of movement, defense and regulation. Arsenic trioxide is passively transported to a lesion position under the volatility of the traditional Chinese medicines to achieve the effects of rupturing membranes and killing viruses, wherein normal tissue is free of influences due to the arsenic trioxide. An enzymatic reaction of combination of main medicines with the organic enzymes in the lesion is referred in the specification. The Japanese encephalitis has the character that leukocyte can increase to (10-20)*10<9>/L. A product of the enzyme can kill the cells. The enzymatic reaction has the three advantages: 1) very high efficiency, wherein the catalytic efficiency of the enzyme is high than that in a non-catalytic reaction by 10<8>-10<20> times and is higher than that of a common catalyst by 10<7>-10<13> times; 2) high specificity, namely, one enzyme only has effects on one or one type of compounds; and 3) adjustability of the enzymatic reaction, which includes regulation on the quantity of generation and degradation of the enzyme, regulation on catalytic performance of the enzyme and regulation through change on medicine concentration.
Any beverage from a range of caffeine free drinks sweetened with non-caloric sweetener. One serving =12oz. Two servings will be consumed daily as part of a structured, weight maintenance diet for 6 months.
Patients will receive capsules of sodium chloride and free water ingestion (for each capsule of sodium chloride, patients will take 250 ml of water, assuring a minimum ingestion of 750 ml of water) in the 48 hours prior contrast injection. Patients will take capsules of sodium chloride at a dose of 100 mg/kg during 48 hours previous the injection of contrast (48, 40, 32, 24, 16, and 8 hours), at the moment of contrast injection and 12 hours after the injection of contrast.
The participants collected data from their hospital.Patients under going non-cardiac surgery were collected. Data of Triglycerides, cholesterol, Low-density lipoprotein and High-density lipoprotein were collected perioperatively. The postoperative major cardiovascular and cerebral events were also identified and collected. Other data including perioperative information and surgeries and anesthesia data were gathered.

Logistic regression models were built and selected. Independent risk factors relative to postoperative major cardiovascular and cerebral events were screened and identified. different levels of Triglycerides, cholesterol, Low-density lipoprotein and High-density lipoprotein were analysed.
The invention discloses an antibacterial solution which is prepared from, by mass, 1-5 parts of stearyl ether-21, 0.5-1 part of stearyl ether-2 and the like. Meanwhile, the invention further discloses a paper diaper prepared through the antibacterial solution. The paper diaper comprises a surface layer (1) made of a non-woven cloth soaked with the antibacterial solution, a flow guide layer (2) which is arranged on the lower side of the surface layer (1) and made of a high-fiber moisture-absorbing strong cloth and the like. In addition, the invention further discloses a preparation method for the paper diaper. The method comprises the steps that 1, the antibacterial solution is prepared; 2, the non-woven cloth is soaked in the antibacterial solution for 20-60 s to prepare an antibacterial non-woven cloth. The center of the flow guide layer of the paper diaper is designed to be in an oval shape, therefore, urine can be quickly dispersed from the middle to the periphery of the paper diaper, the dispersing speed of the paper diaper is 3 times of that of a traditional paper diaper, an absorbing layer can absorb the urine more evenly, and the dry and comfortable degree of the surface layer of the paper diaper is improved.
Patients receive melphalan IV over 30 minutes on day -1. Patients then receive autologous NY-ESO-1 CD4-TCR CD34+ HSC IV on day 0 and autologous NY-ESO-1-specific CD8-positive T lymphocytes IV between days 7 and 21. Patients also receive aldesleukin SC BID for 14 days on the following day after the T cell infusion (between days 8 and 22).
The scientific rationale for this study is the lack of evidence-based treatment for SJS/TEN. The study will aim to establish the most clinically effective therapy for SJS/TEN, as there is currently no level 1A evidence for any treatment above aggressive supportive care which still has equipoise as the standard of care. A multi-centered, two-arm allocated 1:1, double-blind randomized controlled trial with a planned enrollment of 150 patients over 4 years will be undertaken to evaluate which of supportive care or etanercept leads to the shortest time to complete reepithelialization which is the primary outcome. The controlled setting of the clinical trial provides the basis for which samples can be sequentially collected to answer important mechanistic questions. Samples collected during the study will include DNA, PBMC, RNA, plasma, serum, blister fluid cells and supernatant, sloughed epidermis and punch biopsies of skin. Samples will be bio-banked to do immediate targeted high-resolution HLA sequencing, cytokine profiling and single cell multidimensional analyses to identify biological markers that have the potential to predict risk and outcome of SJS/TEN. A population pharmacokinetic study to assess the disposition of etanercept will be done by collecting five samples over the course of the study. Samples will be biobanked for later analysis for other transcriptomic, proteomic whole genome studies. These mechanistic studies will allow us to gain important insights into the immunopathogenesis of SJS/TEN. Our study will be the first to examine in a blinded randomized controlled design both management and mechanisms of SJS/TEN. We anticipate that this will lead to new ways to prevent, diagnosis and treat SJS/TEN, and will create a roadmap and evidence-base for studies in serious immunologically mediated adverse drug reactions and other immunologically mediated diseases.

This protocol represents the only appropriately powered randomized, double-blind mechanistic clinical trial examining therapeutic interventions for SJS/TEN. It will address several significant gaps in knowledge. From a management perspective, it will provide the highest level of supportive care and prove or refute the benefits of etanercept that is a promising therapy for SJS/TEN. The NATIENS trial will also define the standard for systematically assessing the benefit of a systemic intervention for SJS/TEN in prospective studies. We also hope to identify key biomarkers as well as immunologic and genetic determinants for risk, rapid diagnosis, baseline pathophysiology, and mechanisms of response to therapy. The population pharmacokinetics of etanercept will be established for the first time in this critically ill population to improve future dosing strategies and make recommendations. Finally, the protocols and procedures related to patient care will establish a standard for harmonization of care for these patients to provide the best outcomes possible. The study is likely to result in paradigm shifting knowledge regarding SJS/TEN treatment, diagnosis, prevention, and pathogenesis that will lead to improved care for future SJS/TEN patients.
Antibiotics containing low molecular water-soluble chitosan or derivative thereof are provided to secure excellent antifungal activity against pathogenic bacteria, pathogenic yeast mold and mycelium formation mold without cytotoxin. Antibiotics contains water-soluble chitosan with 1000-30,000 of molecular weight or derivative thereof. An amino group(-NH2) of a second carbon or an alcohol group(-OH) of sixth carbon is substituted in the derivative from the water-soluble chitosan. A health food for the antibiosis includes the water-soluble chitosan with 1000-30,000 of molecular weight or derivative thereof. The water-soluble chitosan is easy to be absorbed due to its low molecular weight. The antibiotics hardly show cytotoxin.
Dental caries is an irreversible microbial disease of the calcified tissues of the teeth, characterized by demineralization of the inorganic portion and destruction of the organic substance of the tooth, which often leads to cavitation. It is a complex and dynamic process where a multitude of factors influence and initiate the progression of disease. There are practically no geographic areas in the world whose inhabitants do not exhibit some evidence of dental caries. It affects persons of both genders in all races, all socioeconomic strata and every age group. Likewise, there is strong evidence that tobacco use has numerous negative effects on oral health, for example staining of teeth, dental restoration, development of oral diseases. A biologically reasonable explanation for an association between chewing tobacco use and dental caries may be the presence of higher levels of fermentable sugars in chewing tobacco products which can stimulate the growth of carcinogenic bacteria. The decreased buffering effect possible lower pH of smokers saliva and higher number of lactobacilli and streptococcus mutans group may indicate an increased susceptibility to caries in smokers. On the other hand, there are researches which conclude that presence of extrinsic tobacco stains appear to provide a protective effect from caries.
BACKGROUND: This study assessed the histopathological and oxidative effects of topical Aloe Vera (AV) on penile fractures (PF) formed experimentally in a rat model.
METHODS: Forty Wistar albino rats (220-250 g) were used. The PF model was created experimentally with a number 15 lancet. Then, the rats were randomly and equally divided into five groups. In the first group (C), no incision was formed. In the second group (P), an incision was formed. In the third group (PR), the incision line was closed primarily. In the fourth group (PA), AV was locally applied onto the incision without suturing for three days. In the last group (PRA), AV was applied to the primary repair region for three days. All groups were compared to each other according to histopathological and biochemical data.
RESULTS: Hyperemia-bleeding was observed to be suppressed in the PRA group compared to the other groups (p<0.001). Inflammation was observed only in Groups PR and PRA (p<0.001). Significant fibrosis was observed in the PA and PRA groups compared to the other groups (p<0.001). Superoxide Dismutase (SOD) and Glutathione (GSH) values increased in favor of Group PRA (p=0.009 and p=0.035, respectively). Total Oxidative Status (TOS) and Malondialdehyde (MDA) values decreased in favor of Group PA (p=0.036 and p=0.026, respectively). Tumor Necrosis Factor-alpha (TNF-α) and Interleukin-1 beta (IL-1ß) levels decreased mostly in the PRA group, but these changes did not reach statistical significance (p>0.05).
CONCLUSION: Topical AV application reduces tissue inflammation and oxidative stress but appears to increase the development of fibrosis after PF.
Use of a PDE1A polypeptide (I), or nucleic acid (II) that encodes it, in a test system for identifying inhibitors (A) of (I), suitable for treatment and/or prevention of cardiac insufficiency and the underlying cardiomyopathy. Independent claims are also included for the following: (1) use of (A), including those identified by the new method, for treatment and/or prevention of cardiac insufficiency; and (2) use of PDE1A-specific antibodies (Ab), antisense oligonucleotides and small interfering RNA for treating and/or preventing cardiac insufficiency. ACTIVITY : Cardiant; Antianginal; Hypotensive; Antiarteriosclerotic; Nephrotropic; Vasotropic. MECHANISM OF ACTION : Inhibition of PDE1A, which catalyzes hydrolysis of cGMP, resulting in reduced levels of this antihypertrophic compound in cardiomyocytes, implying that increased expression of PDE1A is responsible for cardiac hypertrophy. Compounds that inhibit PDE1A will thus have an antihypertrophic effect. The rat cardiomyocytic cell line H9C2 was treated with arginine-vasopressin (aVP) to stimulate hypertrophy, detected by increased expression of atrial natriuretic peptide (ANP) and myosin heavy chain beta -subunit (MYCHB). The relative expression in presence of 1 mu M aVP was 72 for ANP and 13 for MYCHB. When 10 mu M of the inhibitory substance X (IC50 for inhibition of PDE1A = 12 nM) was present, the corresponding figures were 18 and 3. Substance X is not identified.
The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array, and in particular a RANKL protein, RANKL fragment or RANKL peptide-VLP-array. More specifically, the invention provides a composition comprising a virus-like particle and at least one RANKL protein, RANKL fragment or RANKL peptide bound thereto. The invention also provides a process for producing the conjugates and the ordered and repetitive arrays, respectively. The compositions of the invention are useful in the production of vaccines for the treatment of bone diseases and as a pharmaccine to prevent or cure bone diseases and to efficiently induce immune responses, in particular antibody responses. Furthermore, the compositions of the invention are particularly useful to efficiently induce self-specific immune responses within the indicated context.
The invention relates to producing mechanically activated amorphous and amorphocrystalline compounds and compositions of gluconic acid calcium salt, to pharmaceutical products based thereon, to a method of the production and the use thereof for treating a wide spectrum of diseases caused by disorders of calcium metabolism in the organism. The inventive method consists in processing a crystalline gluconic acid calcium salt or the compounds thereof with excipients in grinding activator devices to achieve either the input specific energy value equal to or less than 10.4 kJ/g and an amorphocrystalline state, or the input specific energy value equal to or less than 10.5 kJ/g and an amorphous state. The obtained agents are assessed by means of x-ray diffraction, IR, NMR, ESR-spectroscopy, mass- or chromato-mass spectrometry and differential thermal analysis. The mechanically activated amorphous and amorphocrystalline compounds and compositions are used as an active agent for producing pharmaceutical products for therapeutic, medical and preventive and hygienic purposes. The pharmaceutical preparations containing the therapeutically effective amount of active agent are perorally administered 1-6 times a day by doses of 0.2-6 g for at least one month. The invention can be used in the medical and food industries for producing biologically active agents, medicinal and preventive agents, medicinal preparations and for practical medicine for treating acute osseous, dental and other diseases caused by disorders of calcium metabolism in the organism.
Spontaneous pneumomediastinum (SPM) is a rare but described complication of exercise-induced bronchoconstriction (EIB), more commonly observed in children with asthma. We present a 23-year-old active duty military male and avid distance runner who developed progressive radiating retrosternal chest pain preceded by wheezing and coughing paroxysm. A chest computed tomography revealed extensive pneumomediastinum. SPM results from increased intrathoracic pressure with alveolar rupture and subsequent tracking of air between fascial planes. Like most cases of SPM, our patient remained hemodynamically stable and responded well to conservative therapies with complete resolution. After thorough evaluation, undiagnosed asthma was determined to be the inciting etiology. The patient is now well controlled and symptom free on a daily low-dose inhaled corticosteroid without SPM reoccurrence. In young adult patients presenting with SPM, EIB and asthma should be considered on the differential diagnosis as appropriate medical therapy will improve symptoms and reduce risk of reoccurrence.
Methods and apparatus for monitoring a patient are provided. In one arrangement, a multi- dimensional patient data set is received at each of a plurality of different reference times. Each dimension of the patient data set stores a value representing a different type of information about the patient. A plurality of predictions of a health trajectory of the patient are generated. Each prediction is generated using a trained machine learning model receiving as input a different one of the patient data sets. The trained machine learning model may be dimensionally adaptive, such that predictions of the patient trajectories are provided using patient data sets having different respective dimensionalities for at least a sub-set of the reference times. The trained machine learning model may use machine learned predictions of accuracy to select trained machine learning units from an ensemble of trained machine learning units.
Participants in the primary dysmenorrhea study group will be given a general introduction to Pilates-based tele-exercises, and they will be taught five essential elements that they should continuously practice during the exercise process. These elements will be control, breathing, fluidity, precision, and centering. They will be instructed on how to activate the core muscles, including the transverse abdominis, pelvic floor, and multifidus muscles, through isometric contractions while exhaling (centering). The exercises will be conducted over 6 weeks, twice a week, with each session lasting 50 minutes. The exercises, predetermined by the researcher, will be performed under the supervision of a physiotherapist. Each session will be structured into warm-up exercises, main exercises, and cool-down exercises. .